JP2024511292A5 - - Google Patents

Info

Publication number
JP2024511292A5
JP2024511292A5 JP2023553436A JP2023553436A JP2024511292A5 JP 2024511292 A5 JP2024511292 A5 JP 2024511292A5 JP 2023553436 A JP2023553436 A JP 2023553436A JP 2023553436 A JP2023553436 A JP 2023553436A JP 2024511292 A5 JP2024511292 A5 JP 2024511292A5
Authority
JP
Japan
Prior art keywords
cancer
absence
individual
immunotherapy
detecting
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023553436A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024511292A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/GB2022/050561 external-priority patent/WO2022185062A1/en
Publication of JP2024511292A publication Critical patent/JP2024511292A/ja
Publication of JP2024511292A5 publication Critical patent/JP2024511292A5/ja
Pending legal-status Critical Current

Links

JP2023553436A 2021-03-04 2022-03-03 染色体相互作用マーカー Pending JP2024511292A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163156659P 2021-03-04 2021-03-04
US63/156,659 2021-03-04
US202163282284P 2021-11-23 2021-11-23
US63/282,284 2021-11-23
PCT/GB2022/050561 WO2022185062A1 (en) 2021-03-04 2022-03-03 Chromosome interaction markers

Publications (2)

Publication Number Publication Date
JP2024511292A JP2024511292A (ja) 2024-03-13
JP2024511292A5 true JP2024511292A5 (enExample) 2025-03-03

Family

ID=80735500

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023553436A Pending JP2024511292A (ja) 2021-03-04 2022-03-03 染色体相互作用マーカー

Country Status (15)

Country Link
US (1) US20240229135A9 (enExample)
EP (1) EP4301874B1 (enExample)
JP (1) JP2024511292A (enExample)
KR (1) KR20240006020A (enExample)
AU (1) AU2022230780B2 (enExample)
BR (1) BR112023017802A2 (enExample)
CA (1) CA3209544A1 (enExample)
ES (1) ES3029416T3 (enExample)
GB (1) GB2618727B (enExample)
HU (1) HUE071359T2 (enExample)
IL (1) IL304883A (enExample)
PL (1) PL4301874T3 (enExample)
TW (1) TW202302862A (enExample)
WO (1) WO2022185062A1 (enExample)
ZA (1) ZA202309162B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202412610D0 (en) * 2024-08-28 2024-10-09 Oxford BioDynamics PLC Screening method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511930B (zh) * 2017-11-03 2024-11-22 牛津生物动力有限责任公司 通过染色体相互作用遗传调节免疫响应
WO2020198676A1 (en) * 2019-03-28 2020-10-01 Bristol-Myers Squibb Company Methods of treating tumor
GB2626699B (en) * 2019-05-08 2024-11-20 Oxford BioDynamics PLC Chromosome Conformation Markers of Prostate Cancer and Lymphoma
WO2021228888A1 (en) * 2020-05-12 2021-11-18 Asylia Diagnostics Biomarkers for hyperprogressive disease and therapy response after immunotherapy

Similar Documents

Publication Publication Date Title
JP2018033463A (ja) クランピングプローブ及び検出プローブを用いた多重標的核酸の検出方法
TWI893039B (zh) 透過循環腫瘤dna分析之分子疾病評估之方法及系統
US20070117134A1 (en) Method for detection and quantification of T-cell receptor Vbeta repertoire
CA2772123C (en) Binding-induced hairpin detection system
JP2021501592A5 (enExample)
RS59710B1 (sr) Metod određivanja mutacionog statusa pik3ca u uzorku
CN108138209A (zh) 通过原位扩增制备细胞游离核酸分子的方法
US20240263241A1 (en) Methods and compositions for copy-number informed tissue-of-origin analysis
US11230738B2 (en) Methods for detection and quantification of EGFRvIII in the peripheral blood of GBM patients
CN111511930A (zh) 通过染色体相互作用遗传调节免疫响应
JP2024504062A5 (enExample)
CN104480215B (zh) 一种基因联合检测方法及试剂盒
GB2617795A (en) Chromosome interactions
GB2618727A (en) Chromosome interaction markers
JP2021501598A (ja) 免疫療法に対する悪性疾患の応答性を決定するための方法
GB2597895A (en) Chromosome conformation markers of prostate cancer and lymphoma
JP2023528621A5 (enExample)
Wang et al. Identification of the insertion site of transgenic DNA based on cyclization of the target gene with the flanking sequence and nested inverse PCR
US10227655B2 (en) Method for analyzing body fluid samples
GB2604247A (en) Diagnostic chromosome marker
RU2012124108A (ru) Олигонуклеотидные праймеры - зонд, способ и тест-система для выявления генома вируса болезни шмалленберг методом обратной транскрипции - полимеразной цепной реакции в реальном времени
KR20240007765A (ko) 표적 핵산을 농축하는 방법, 오프-타겟을 식별하고 유전자 편집 효율성을 평가하는 방법
JP2018038341A (ja) 標的核酸の高感度検出方法
RU2667648C1 (ru) Аналитическая тест-система по определению чувствительности злокачественной опухоли конкретного пациента к онколитической биотерапии
Shagin et al. Application of nonsense-mediated primer exclusion (NOPE) for preparation of unique molecular barcoded libraries